Glyphosate works by inhibiting an enzyme in plants known as EPSP synthase, which they need in order to grow. Without this enzyme, a plant will not be able to produce other proteins necessary for survival. Monsanto has profited incredibly from this chemical – in fact, during fiscal year 2015 alone the company raked in nearly $5 billion in revenue from RoundUp, according to financial records.
Researchers have claimed for years that glyphosate poses a substantial risk to humans as well as animals. However, momentum against use of the chemical ramped up considerably in March 2015 thanks to a report issued by the World Health Organization (WHO). The International Agency for Research on Cancer, a subsidiary of the WHO, classified glyphosate as a probable carcinogen. It cited 15 years worth of research studies that showed the chemical could cause the development of non-Hodgkin’s lymphoma as well as other forms of cancer.
But research questioning the safety of glyphosate goes back even further. For instance, a team of French researchers published a 2005 study that found human placental cells could be damaged by even minimal exposure to glyphosate. Another study showed the chemical could increase the risk of attention deficit disorder, reduce the production of sex hormones, and also result in genetic damage to both humans and animals.
Contact Baron & Budd
Baron & Budd is investigating potential lawsuits against Monsanto on behalf of people who have developed cancer after exposure to RoundUp, whether they were farm workers or they lived nearby areas where the weed killer is used regularly. Please complete our contact form or 866-223-3424 to learn more.